Lead Pharma has signed a collaboration and licence agreement with Roche for the development of oral small molecules to treat a broad range of immune-mediated diseases.
Lead Pharma, a clinical stage pharmaceutical company, has entered into a collaboration and license agreement with Roche to develop oral small molecules to treat a broad range of immune mediated diseases.